On July 4th, Gelunhui reported that Changjiang Pharmaceutical Group (300391.SZ), which had limit-up for two consecutive days with a 20cm increase, once fell sharply by 12% during the session, and is now reported at 3.12 yuan, with a decline narrowed to 7.7%, and a total market value of 1.1 billion yuan. The company released a notice on the abnormal stock price movement yesterday evening, alerting investors to a series of risks currently faced by the company, including large accumulated losses, unresolved illegal guarantees, involvement in multiple litigation and arbitration cases, frozen bank accounts, and other situations. In addition, a new court lawsuit was filed recently, for securities false statement liability disputes.
A股异动丨提示风险 长药控股一度大跌12% 此前连续2日涨停
A shares fluctuate | Warning risk, Changjiang Pharmaceutical Group once fell by 12%. Prior to this, it had two consecutive days of daily limit increases.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.